Submitted by dcc on Mon, 2020-02-10 11:47 Study Title: Determining the Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients with GliomasCIRB: Adult CIRB - Late Phase EmphasisLead Group: ABTCStatus: ActiveReview Status: Available to Open
